Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2010
Biologically targeted cancer therapy and marginal benefits: are we making too much of too little or are we achieving too little by giving too much?Tito Fojo, David R ParkinsonCurrent Opinion in Molecular Therapeutics|May 30, 2009
Patient-specific classifications of human malignant diseaseDavid R Parkinson, Alessandra CesanoAutoimmunity|May 21, 2010
Single-cell network profiling (SCNP) by flow cytometry in autoimmune diseaseTodd M Covey, Alessandra Cesano, David R ParkinsonClinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2012
Making personalized cancer medicine a reality: challenges and opportunities in the development of biomarkers and companion diagnosticsDavid R Parkinson, Bruce E Johnson, George W SledgeClinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2012
Leveling the playing field: bringing development of biomarkers and molecular diagnostics up to the standards for drug developmentGeorge Poste, David P Carbone, David R Parkinson, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2014
Evidence of clinical utility: an unmet need in molecular diagnostics for patients with cancerDavid R Parkinson, Robert T McCormack, Susan M Keating, et al.Journal of Translational Medicine|July 4, 2012
Considerations in the development of circulating tumor cell technology for clinical useDavid R Parkinson, Nicholas Dracopoli, Brenda Gumbs Petty, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2003
Soft tissue sarcomas of adults: state of the translational scienceErnest C Borden, Laurence H Baker, Robert S Bell, et al.Pageof 1